Senzime is a leading global medical device company, developing precision-based patient monitoring solutions that drive a global paradigm shift in perioperative patient safety. Our cutting-edge solutions TetraGraph® and ExSpiron 2Xi are powered by proprietary, smart algorithms to monitor neuromuscular and respiratory functions during and after surgery. With our dedicated team and strong partnerships, we are on a global mission to safeguard every patient's journey, from anesthesia to recovery. Established in 1999, Senzime is backed by long-term investors and listed on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the New York OTCQX market (SNZZF). #Senzime #TetraGraph #PatientsSfety #TOFMonitoring #Anesthesia
Looking for a particular Senzime employee's phone or email?
Senzime Questions
The Senzime annual revenue was $8 million in 2026.
Johanna Tulkki is the COO and EVP of Senzime.
54 people are employed at Senzime.
Senzime is based in Uppsala, Uppsala County.
The NAICS codes for Senzime are [334, 33].
The SIC codes for Senzime are [38, 384].
Top Senzime Employees
-
Johanna Tulkki
COO and EVP at Senzime
Uppsala, SE21 -
Philip Siberg
Chief Executive Officer at Senzime
Stockholm, SE23 -
Anders Jacobson
Chief Innovation Officer at Senzime
Uppsala, Uppsala County, SE2 -
George Hamilton
President and General Manager at Senzime
St. Louis, MO, US24 -
Michael Noble
Chief Marketing Officer at Senzime
Dallas, TX, US23 -
Sorin Brull
Chief Medical Officer at Senzime
Ponte Vedra Beach, FL, US32 -
Christopher Estes
President and General Manager at Senzime
Immokalee, FL, US -
Josi Wood
Vice President US Sales at Senzime
Kansas City, MO, US11 -
22
-
Johanna Faris
Quality Assurance and Regulatory Affairs Director at Senzime
Uppsala, Uppsala County, SE2
Related Companies
